Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt IssuancesReceivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Safe Bulkers (SB) Receivables - Other (2016 - 2025)

Safe Bulkers' Receivables - Other history spans 14 years, with the latest figure at $615000.0 for Q4 2025.

  • For Q4 2025, Receivables - Other fell 31.89% year-over-year to $615000.0; the TTM value through Dec 2025 reached $615000.0, down 31.89%, while the annual FY2025 figure was $615000.0, 31.89% down from the prior year.
  • Receivables - Other reached $615000.0 in Q4 2025 per SB's latest filing, down from $903000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $903000.0 in Q4 2024 to a low of $564000.0 in Q4 2023.
  • Average Receivables - Other over 5 years is $681800.0, with a median of $662000.0 recorded in 2022.
  • Peak YoY movement for Receivables - Other: skyrocketed 60.11% in 2024, then tumbled 31.89% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $665000.0 in 2021, then fell by 0.45% to $662000.0 in 2022, then fell by 14.8% to $564000.0 in 2023, then skyrocketed by 60.11% to $903000.0 in 2024, then crashed by 31.89% to $615000.0 in 2025.
  • Per Business Quant, the three most recent readings for SB's Receivables - Other are $615000.0 (Q4 2025), $903000.0 (Q4 2024), and $564000.0 (Q4 2023).